[13] have found that IL18R may promote airway remodeling in patients with asthma by inducing epithelial cell differentiation, epithelial repair, and changes in the expression of epithelial-mesenchymal transition (EMT) proteins. This evidence concerns the gene IL18R1 and asthma.